Pathology
 |
|
12 november 2019 22:00:53 |
| Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN (Leukemia) |
|
Tweet |
| 176 viewsCategory: Pathology |
 Need for routine examination of left ventricular ejection fraction in patients with AML (Leukemia)Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma (Leukemia) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
